BTIG maintains $178 price target on Nektar Therapeutics
BTIG maintained a $178.00/share price target on Nektar Therapeutics (NKTR), according to ratings actions
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.